I.-Without prejudice to the provisions of II, the Agence nationale de sécurité du médicament et des produits de santé has the status of competent authority for the implementation of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017, under the conditions specified by the provisions of this Part.
In this capacity, the agency shall in particular:
1° The tasks provided for at the stage of placing on the market, putting into service or making available on the market the devices mentioned in Article 1 of Regulation (EU) 2017/745;
2° Verification of the data transmitted when registering economic operators for the purposes of issuing the unique registration number ;
3° Vigilance, for the implementation of Section 2 of Chapter VII of Regulation (EU) 2017/745;
4° Post-marketing surveillance, for the implementation of Section 1 of Chapter VII of Regulation (EU) 2017/745;
5° Market surveillance, for the implementation of Section 3 of the same Chapter VII concerning:
(a) Medical devices and their accessories;
(b) The groups of products listed in Annex XVI to Regulation (EU) 2017/745, with the exception of those exclusively intended for direct use by consumers or by professional users, other than healthcare professionals, as part of a service intended for consumers.
The Agency shall be the authority responsible for notified bodies in accordance with the provisions of Article 35 of Regulation (EU) 2017/745.
II.-The administrative authority responsible for competition and consumer affairs mentioned in Article L. 522-1 of the Consumer Code also acts as the competent authority for post-marketing surveillance and market surveillance for the products mentioned in Article 1 of Regulation (EU) 2017/745 when they are intended to be used directly by consumers or by professional users, other than healthcare professionals, as part of a service intended for consumers.